Pain Therapeutics, Inc

Pain Therapeutics, Inc

Pain Therapeutics, Inc. is a biopharmaceutical company, that engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States. Its Phase III clinical trial products include Remoxy, which is an anti-abuse version of long-acting oxycodone; and Oxytrex, which is an opioid painkiller for the treatment of chronic pain. The company has a strategic alliance with King Pharmaceuticals, Inc. for the development and commericalization of Remoxy and other abuse-resistant opioid painkillers. Pain Therapeuctics was founded in 1998...
more

quick facts
NASDAQ symbol:PTIE
Founded:1998
Headquarters:South San Francisco, California
Annual revenue:$63,730,000
Net income:$15,350,000
Operating income:$8,710,000
Market cap:$470,000,000
Industries:Pharmaceutical Preparations

Revenue history for Pain Therapeutics, Inc

RevenueDate
$63,730,000 December 31, 2008
$53,900,000 December 31, 2006
« Prev  Next »

Net income history for Pain Therapeutics, Inc

Net IncomeDate
$15,350,000 December 31, 2008
« Prev  Next »

Headquarters of Pain Therapeutics, Inc

South San Francisco
South San Francisco
Population:63,632

South San Francisco is a city in San Mateo County, California, United States, located on the San Francisco Peninsula in the San Francisco Bay Area. The population was 63,632 at the 2010 census. South San Francisco lies north of San Bruno and San Francisco International Airport in a small valley...
more

Current Pain Therapeutics, Inc board members

Vernon R Loucks Jr
Vernon R Loucks Jr
Board member since:2003

Vernon R. Loucks Jr. is Chairman and Chief Executive Officer of Baxter International Inc., having served in the latter capacity since May 1980. Mr....
more

Companies in the Same City

Genentech
Genentech
Revenue: $9,284,000,000
Core-Mark Holding Company, Inc.
Core-Mark Holding Company, Inc.
Revenue: $6,044,900,000
Actuate
Actuate
Revenue: $130,990,000
Exelixis
Exelixis
Revenue: $117,860,000
Monogram Biosciences
Monogram Biosciences
Revenue: $48,000,000
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
Revenue: $33,500,000
Theravance
Theravance
Revenue: $23,100,000
Cytokinetics Inc.
Cytokinetics Inc.
Revenue: $12,420,000
Renovis, Inc.
Renovis, Inc.
Revenue: $10,400,000
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
Revenue: $5,420,000
Tercica
Tercica
Revenue: $1,500,000
Threshold Pharmaceuticals
Threshold Pharmaceuticals
Revenue: $1,440,000

Frequently Asked Questions

  • Q:
    Who has purchased shares of stock in Pain Therapeutics, Inc?
  • A:
    The company's major shareholders include Remi Barbier.
  • Q:
    Which market sectors does Pain Therapeutics, Inc operate?
  • A:
    The company operates in Pharmaceutical Preparations.
  • Q:
    Which location is Pain Therapeutics, Inc's headquarters?
  • A:
    The main office is located in South San Francisco, California.
  • Q:
    Who are the Board Members at Pain Therapeutics, Inc?
  • A:
    A few Board Members include:
    - Nadav Friedmann, Board Member
    - Remi Barbier, Board Member
    - Robert Z Gussin, Board Member
    - Vernon R Loucks Jr, Board Member
    - Donnell Michael J O, Board Member
    - Sanford Robertson, Board Member
  • Q:
    What is the stock ticker symbol and exchange for Pain Therapeutics, Inc?
  • A:
    The stock ticker is "PTIE" listed on the NASDAQ stock exchange.
  • Q:
    Which year was Pain Therapeutics, Inc founded?
  • A:
    The business was founded in 1998.
Pain Therapeutics, Inc
Top of Page © 2012 Juggle, LLC
All Rights Reserved
Encyclopedia & Reference Resource
Some of the content on this page was provided by other sites, including
Freebase Icon (Pain Therapeutics, Inc) or others licensed under Creative Commons